Age–Bilirubin–International Normalized Ratio (INR)–Creatinine (ABIC) Score, a Potential Prognostic Model for Long-Term Mortality of CAD Patients After PCI

References

• Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi:10.1371/journal.pmed.0030442
   PubMed Web of Science ®Google Scholar
• Steg PG, Bhatt DL, Wilson PW, et al.; REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297(11):1197–1206. doi:10.1001/jama.297.11.1197
   PubMed Web of Science ®Google Scholar
• Bettinger N, Palmerini T, Caixeta A, et al. Risk stratification of patients undergoing medical therapy after coronary angiography. Eur Heart J. 2016;37(40):3103–3110. doi:10.1093/eurheartj/ehv674
   Web of Science ®Google Scholar
• Levelt E, Rodgers CT, Clarke WT, et al. Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus. Eur Heart J. 2016;37(46):3461–3469. doi:10.1093/eurheartj/ehv442
   PubMed Web of Science ®Google Scholar
• Tada H, Kawashiri MA, Nohara A, Inazu A, Mabuchi H, Yamagishi M. Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia. Eur Heart J. 2017;38(20):1573–1579. doi:10.1093/eurheartj/ehx004
   PubMed Web of Science ®Google Scholar
• Tibaut M, Caprnda M, Kubatka P, et al. Markers of atherosclerosis: part 1 - serological markers. Heart Lung Circ. 2019;28(5):667–677. doi:10.1016/j.hlc.2018.06.1057
   PubMed Web of Science ®Google Scholar
• Tibaut M, Caprnda M, Kubatka P, et al. Markers of atherosclerosis: part 2 - genetic and imaging markers. Heart Lung Circ. 2019;28(5):678–689. doi:10.1016/j.hlc.2018.09.006
   PubMed Web of Science ®Google Scholar
• Dominguez M, Rincón D, Abraldes JG, et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am J Gastroenterol. 2008;103(11):2747–2756. doi:10.1111/j.1572-0241.2008.02104.x
   PubMed Web of Science ®Google Scholar
• Chen L, Zheng J, Cai J, et al. Age-bilirubin-international normalized ratio-creatinine score in short-term survival of acute-on-chronic hepatitis B liver failure. Cell Physiol Biochem. 2018;51(5):2484–2495. doi:10.1159/000495904
   Google Scholar
• Kerneis M, Yee MK, Mehran R, et al. Association of international normalized ratio stability and bleeding outcomes among atrial fibrillation patients undergoing percutaneous coronary intervention. Circ Cardiovasc Interv. 2019;12(2):e007124. doi:10.1161/CIRCINTERVENTIONS.118.007124
   Web of Science ®Google Scholar
• Gajanana D, Rogers T, Iantorno M, et al. Antiplatelet and anticoagulation regimen in patients with mechanical valve undergoing PCI - state-of-the-art review. Int J Cardiol. 2018;264:39–44. doi:10.1016/j.ijcard.2018.03.107
   Web of Science ®Google Scholar
• Chung SR, Yang TH, Shin HC, et al. Initial total bilirubin and clinical outcome in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stents. Circ J. 2016;80(6):1437–1444. doi:10.1253/circj.CJ-15-1397
   PubMed Web of Science ®Google Scholar
• Zhang MM, Gao Y, Zheng YY, et al. Association of fasting serum bilirubin levels with clinical outcomes after percutaneous coronary intervention: a prospective study. Cardiovasc Toxicol. 2017;17(4):471–477. doi:10.1007/s12012-017-9405-3
   PubMed Web of Science ®Google Scholar
• Guo XS, Chen SQ, Duan CY, et al. Association of post-procedural early (within 24h) increases in serum creatinine with all-cause mortality after coronary angiography. Clin Chim Acta. 2017;474:96–101. doi:10.1016/j.cca.2017.08.036
   Web of Science ®Google Scholar
• Zheng YY, Wu TT, Chen Y, et al. Resting heart rate and long-term outcomes in patients with percutaneous coronary intervention: results from a 10-year follow-up of the CORFCHD-PCI study. Cardiol Res Pract. 2019;2019:5432076. doi:10.1155/2019/5432076
   Web of Science ®Google Scholar
• Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16(4):203–212. doi:10.1038/s41569-018-0119-4
   PubMed Web of Science ®Google Scholar
• Mezue K, Rangaswami J. Directly observed therapy: a possible tool to tackle medication nonadherence in the CVD epidemic. J Am Coll Cardiol. 2017;69(24):3009. doi:10.1016/j.jacc.2017.02.076
   Web of Science ®Google Scholar
• Castellano JM, Sanz G, Fernandez Ortiz A, Garrido E, Bansilal S, Fuster V. A polypill strategy to improve global secondary cardiovascular prevention: from concept to reality. J Am Coll Cardiol. 2014;64(6):613–621. doi:10.1016/j.jacc.2014.06.009
   PubMed Web of Science ®Google Scholar
• Daly CA, De Stavola B, Sendon JL, et al.; Euro Heart Survey Investigators. Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational study. BMJ. 2006;332(7536):262–267. doi:10.1136/bmj.38695.605440.AE
   PubMedGoogle Scholar
• Clayton TC, Lubsen J, Pocock SJ, et al. Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients. BMJ. 2005;331(7521):869. doi:10.1136/bmj.38603.656076.63
   Google Scholar
• Marschner IC, Colquhoun D, Simes RJ, et al.; LIPID Study Investigators. Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. J Am Coll Cardiol. 2001;38(1):56–63. doi:10.1016/S0735-1097(01)01360-2
   Web of Science ®Google Scholar
• Rapsomaniki E, Shah A, Perel P, et al. Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients. Eur Heart J. 2014;35(13):844–852. doi:10.1093/eurheartj/eht533
   PubMed Web of Science ®Google Scholar
• Lee JH, Bae MH, Yang DH, et al.; Korea Acute Myocardial Infarction Registry Investigators. Prognostic value of the age, creatinine, and ejection fraction score for 1-year mortality in 30-day survivors who underwent percutaneous coronary intervention after acute myocardial infarction. Am J Cardiol. 2015;115(9):1167–1173. doi:10.1016/j.amjcard.2015.02.001
   Web of Science ®Google Scholar
• Di Serafino L, Borgia F, Maeremans J, et al. The age, creatinine, and ejection fraction score to risk stratify patients who underwent percutaneous coronary intervention of coronary chronic total occlusion. Am J Cardiol. 2014;114(8):1158–1164. doi:10.1016/j.amjcard.2014.07.034
   Web of Science ®Google Scholar
• Deng J, Wang X, Shi Y, Zhao X, Han Y. Prognostic value of the age, creatinine, and ejection fraction score for non-infarct-related chronic total occlusion revascularization after primary percutaneous intervention in acute ST-elevation myocardial infarction patients: a retrospective study. J Interv Cardiol. 2018;31(1):33–40. doi:10.1111/joic.12448
   PubMed Web of Science ®Google Scholar
• Nakahashi T, Tada H, Sakata K, et al. Additive prognostic value of carotid plaque score to enhance the age, creatinine, and ejection fraction score in patients with acute coronary syndrome. J Atheroscler Thromb. 2018;25(8):709–719. doi:10.5551/jat.42317
   Web of Science ®Google Scholar
• Reindl M, Reinstadler SJ, Tiller C, et al. ACEF score adapted to ST-elevation myocardial infarction patients: the ACEF-STEMI score. Int J Cardiol. 2018;264:18–24. doi:10.1016/j.ijcard.2018.04.017
   Web of Science ®Google Scholar
• Yao ME, Su MY, Huang Y, Chen W. Physiologically increased total bilirubin is associated with reduced risk of first myocardial infarction: a meta-analysis and dose-response analysis. Nutr Metab Cardiovasc Dis. 2021;31(4):1016–1026. doi:10.1016/j.numecd.2021.01.002
   Web of Science ®Google Scholar
• Li XL, Zhao CR, Pan CL, Jiang G, Zhang B. Role of bilirubin in the prognosis of coronary artery disease and its relationship with cardiovascular risk factors: a meta-analysis. BMC Cardiovasc Disord. 2022;22(1):458. doi:10.1186/s12872-022-02899-w
   Web of Science ®Google Scholar
• Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem. 1994;269(24):16712–16719. doi:10.1016/S0021-9258(19)89449-8
   PubMed Web of Science ®Google Scholar
• Campo G, Pavasini R, Pollina A, Tebaldi M, Ferrari R. Coagulation factors and recurrence of ischemic and bleeding adverse events in patients with acute coronary syndromes. Thromb Res. 2013;132(2):151–157. doi:10.1016/j.thromres.2013.06.007
   Web of Science ®Google Scholar
• Liu L, Ying M, Chen S, et al. The association between prothrombin time-international normalized ratio and long-term mortality in patients with coronary artery disease: a large cohort retrospective study with 44,662 patients. BMC Cardiovasc Disord. 2022;22(1):297. doi:10.1186/s12872-022-02619-4
   Web of Science ®Google Scholar
• Dorgalaleh A, Favaloro EJ, Bahraini M, Rad F. Standardization of Prothrombin Time/International Normalized Ratio (PT/INR). Int J Lab Hematol. 2021;43(1):21–28. doi:10.1111/ijlh.13349
   PubMed Web of Science ®Google Scholar
• Levi M, van der Poll T, Büller HR. Bidirectional relation between inflammation and coagulation. Circulation. 2004;109(22):2698–2704. doi:10.1161/01.CIR.0000131660.51520.9A
   PubMed Web of Science ®Google Scholar
• Di Mauro M, Fiorentini V, Mistrulli R, Veneziano FA, De Luca L. Acute coronary syndrome and renal impairment: a systematic review. Rev Cardiovasc Med. 2022;23(2):49. doi:10.31083/j.rcm2302049
   Web of Science ®Google Scholar
• Sarnak MJ, Amann K, Bangalore S, et al.; Conference Participants. Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74(14):1823–1838. doi:10.1016/j.jacc.2019.08.1017
   PubMed Web of Science ®Google Scholar